Kobe, Japan

Ryohei Sasaki

This inventor holds 1 USPTO granted patent. Top assignee: Kobe University. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryohei Sasaki. Retrieved from https://idiyas.com/inventor/ryohei-sasaki-bk65rc39

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ryohei Sasaki: Innovator in Radiation Therapy

Introduction

Ryohei Sasaki is a prominent inventor based in Kobe, Japan. He has made significant contributions to the field of radiation therapy, particularly through his innovative patent that enhances the effectiveness of radiotherapeutic agents. His work aims to improve patient outcomes while minimizing side effects.

Latest Patents

Ryohei Sasaki holds a patent for a radiotherapeutic agent that includes a composite particle. This agent is designed to bind a molecule that specifically recognizes a target to a substrate particle made of titanium peroxide. The unique feature of this agent is its ability to generate reactive oxygen when irradiated, which enhances the effects of radiotherapy. Additionally, the agent's targeting capability allows it to accumulate in specific areas, thereby efficiently attacking the target while reducing side effects on the living body.

Career Highlights

Sasaki is affiliated with Kobe University, where he continues to advance research in the field of radiation therapy. His innovative approach has garnered attention in the medical community, highlighting the potential for improved treatment options for patients undergoing radiotherapy.

Collaborations

Some of Ryohei Sasaki's notable coworkers include Tsutomu Tanaka and Chiaki Ogino. Their collaborative efforts contribute to the ongoing research and development of effective radiotherapeutic solutions.

Conclusion

Ryohei Sasaki's work in developing a targeted radiotherapeutic agent represents a significant advancement in cancer treatment. His innovative approach not only enhances the efficacy of radiotherapy but also aims to reduce the associated side effects, marking a promising direction for future medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…